Design and Synthesis of Novel Hybrid Molecules against Malaria

<div>The first component of the hybrid drugs (<i>rac</i>)-primaquine (<b>1</b>) and its pharmacophore moiety (in green,<b> 4</b>) as well as the second drug (<i>rac</i>)-chloroquine (<b>2</b>) and the corresponding pharmacophore structure (in blue,<b> 3</b>).</div>

International Journal of Medicinal Chemistry

fig1

Figure 1

Figure 1: Design and Synthesis of Novel Hybrid Molecules against Malaria 